Clinical and Applied Thrombosis/Hemostasis
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 44.0% | 0.671 | Q2 | 71.5% |
| 2024 | 2.0 | Q3 | 43.4% | 0.635 | Q2 | 70.4% |
| 2023 | 2.3 | Q2 | 53.3% | 0.633 | Q2 | 72.6% |
| 2022 | 2.9 | Q3 | 61.1% | 0.678 | Q2 | 75.8% |
| 2021 | 3.5 | Q3 | 60.9% | 0.758 | Q2 | 79.7% |
| 2020 | — | — | 0.643 | Q2 | 73.8% | |
| 2019 | — | — | 0.495 | Q2 | 67.3% | |
| 2018 | — | — | 0.452 | Q2 | 62.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1938-2723
ISSN
1076-0296
country
UScoverage
1995-2026